RATIONALE: Previous studies have demonstrated reductions of serotonin 5-HT 2A receptors in the neocortex of Alzheimer's disease (AD) patients. However, it is unclear whether such losses play a role in the cognitive decline of AD. OBJECTIVES: To correlate neocortical 5-HT 2A receptor alterations with cognitive decline in AD. METHODS: Postmortem frontal and temporal cortical 5-HT 2A receptors were measured by [3H]ketanserin binding in aged controls as well as in a cohort of AD patients who had been longitudinally assessed for cognitive decline and behavioral symptoms. RESULTS: 5-HT 2A receptor densities in both regions were reduced in severely demented AD patients compared to age-matched controls. In the temporal cortex, this reduction also correlated with the rate of decline of Mini-Mental State Examination (MMSE) scores. The association between 5-HT 2A receptor loss and cognitive decline was independent of the effects of choline acetyltransferase (ChAT) activity and presence of behavioral symptoms. CONCLUSIONS: Our data suggest that loss of neocortical 5-HT 2A receptors may predict for faster cognitive decline in AD, and point to serotomimetics as potentially useful adjuvants to cholinergic replacement therapies.
RATIONALE: Previous studies have demonstrated reductions of serotonin 5-HT 2A receptors in the neocortex of Alzheimer's disease (AD) patients. However, it is unclear whether such losses play a role in the cognitive decline of AD. OBJECTIVES: To correlate neocortical 5-HT 2A receptor alterations with cognitive decline in AD. METHODS: Postmortem frontal and temporal cortical 5-HT 2A receptors were measured by [3H]ketanserin binding in aged controls as well as in a cohort of ADpatients who had been longitudinally assessed for cognitive decline and behavioral symptoms. RESULTS:5-HT 2A receptor densities in both regions were reduced in severely demented ADpatients compared to age-matched controls. In the temporal cortex, this reduction also correlated with the rate of decline of Mini-Mental State Examination (MMSE) scores. The association between 5-HT 2A receptor loss and cognitive decline was independent of the effects of choline acetyltransferase (ChAT) activity and presence of behavioral symptoms. CONCLUSIONS: Our data suggest that loss of neocortical 5-HT 2A receptors may predict for faster cognitive decline in AD, and point to serotomimetics as potentially useful adjuvants to cholinergic replacement therapies.
Authors: J Blin; J C Baron; B Dubois; C Crouzel; M Fiorelli; D Attar-Lévy; B Pillon; D Fournier; M Vidailhet; Y Agid Journal: Brain Date: 1993-06 Impact factor: 13.501
Authors: Mitchell K P Lai; Shirley W Y Tsang; Paul T Francis; Janet Keene; Tony Hope; Margaret M Esiri; Ian Spence; Christopher P L-H Chen Journal: Neuroreport Date: 2002-07-02 Impact factor: 1.837
Authors: Mitchell K P Lai; Shirley W Tsang; Margaret M Esiri; Paul T Francis; Peter T-H Wong; Christopher P Chen Journal: Psychopharmacology (Berl) Date: 2010-07-13 Impact factor: 4.530
Authors: Saikat Chakraborty; Jack C Lennon; Sridhar A Malkaram; Yan Zeng; Daniel W Fisher; Hongxin Dong Journal: Neurosci Lett Date: 2019-04-01 Impact factor: 3.046
Authors: D M Bowen; A W Procter; D M A Mann; J S Snowden; M M Esiri; D Neary; P T Francis Journal: Psychopharmacology (Berl) Date: 2007-11-18 Impact factor: 4.530
Authors: Thelma Schilt; Maarten W J Koeter; Johan P Smal; Mathilde N Gouwetor; Wim van den Brink; Ben Schmand Journal: Psychopharmacology (Berl) Date: 2009-10-13 Impact factor: 4.530
Authors: Mitchell K P Lai; Michelle G K Tan; Sara Kirvell; Carl Hobbs; Jasinda Lee; Margaret M Esiri; Christopher P Chen; Paul T Francis Journal: J Neural Transm (Vienna) Date: 2008-05-28 Impact factor: 3.575